M&A Deal Summary |
|
|---|---|
| Date | 2022-01-18 |
| Target | Anacapa Technologies |
| Sector | Consumer Products |
| Buyer(s) | Argentum |
| Deal Type | Add-on Acquisition |
SEARCH BY
Argentum is a manufacturer and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® (“Silverlon”) brand, its rapidly-growing, proprietary range of silver-based antimicrobial products. The core platform technology in Silverlon is a uniquely designed silver-plated nylon matrix that provides the powerful antimicrobial properties of silver ions in the dressing without staining the skin and without increasing bioburden. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure wound therapy. Argentum was founded in 2001 and is based in Geneva, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-05 |
TheraBond
Yardley, Pennsylvania, United States The TheraBond® product line is based on a proprietary and patented manufacturing process where silver is bonded to the entire surface of all fibers of the TheraBond® dressing. When TheraBond® products are placed on the wound, bioactive ionic silver is released in the dressing at a controlled rate, promoting an optimal wound healing environment by creating an antimicrobial barrier to more effectively protect the wound. |
Buy | $4M |
